Quinimon, Carmela M.

HRN: 05-26-54  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2022
CO-AMOXICLAV 625MG (TAB)
11/29/2022
12/05/2022
ORAL
500mg
Q12Hrs
Covid-19 Pneumonia - Mild
Waiting Final Action 
01/13/2023
CEFUROXIME 500MG (TAB)
01/13/2023
01/20/2023
ORAL
1 Tab
BID
Incomplete Abortion
Waiting Final Action 
01/13/2023
MEBENDAZOLE 500MG (TAB)
01/13/2023
01/20/2023
ORAL
1 Tab
TID
Incomplete Abortion
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: